Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation ; day:24 ; month:4 ; year:2020 ; pages:1-9
Annals of hematology ; (24.4.2020), 1-9
- Urheber
-
Helbig, Grzegorz
Koclęga, Anna
Wieczorkiewicz-Kabut, Agata
Woźniczka, Krzysztof
Kopińska, Anna
Boral, Kinga
Grygoruk-Wiśniowska, Iwona
Stachowicz, Małgorzata
Karolczyk, Agnieszka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-020-04026-1
- URN
-
urn:nbn:de:101:1-2020070421593475353041
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Helbig, Grzegorz
- Koclęga, Anna
- Wieczorkiewicz-Kabut, Agata
- Woźniczka, Krzysztof
- Kopińska, Anna
- Boral, Kinga
- Grygoruk-Wiśniowska, Iwona
- Stachowicz, Małgorzata
- Karolczyk, Agnieszka
- SpringerLink (Online service)
Ähnliche Objekte (12)
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Role of FLT3 ITD PTPRC signaling in bone remodeling
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Role of FLT3 ITD PTPRC signaling in bone remodeling
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
Role of FLT3 ITD PTPRC signaling in bone remodeling
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML